carvedilol phosphate 40 mg
1 INDICATIONS AND USAGE Carvedilol phosphate extended-release capsules are an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure. ( 1.1 ) left ventricular dysfunction following myocardial infarction in clinically stable patients. ( 1.2 ) hypertension. ( 1.3 ) 1.1 Heart Failure Carvedilol phosphate extended-release capsules are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions (7.4) , Clinical Studies (14.1) ]. 1.2 Left Ventricular Dysfunction following Myocardial Infarction Carvedilol phosphate extended-release capsules are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies (14.2) ]. 1.3 Hypertension Carvedilol phosphate extended-release capsules are indicated for the management of essential hypertension [see Clinical Studies (14.3 , 14.4 )] . They can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics [see Drug Interactions (7.2) ] .
Amneal Pharmaceuticals of New York LLC
CAPSULE ORANGE H33
Related Pills
carvedilol phosphate 20 mg
Amneal Pharmaceuticals of New York LLC
carvedilol phosphate 10 mg
Amneal Pharmaceuticals of New York LLC
carvedilol phosphate 10 mg
amneal pharmaceuticals of new york llc
carvedilol phosphate 20 mg
amneal pharmaceuticals of new york llc
carvedilol phosphate 40 mg
amneal pharmaceuticals of new york llc
carvedilol phosphate 80 mg
amneal pharmaceuticals of new york llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING The hard gelatin extended-release capsules are available in the following strengths: 10 mg – capsules with white opaque body imprinted with “H31” in black ink and dark green opaque cap. Bottles of 30: NDC 0115-1248-08 Bottles of 90: NDC 0115-1248-10 Bottles of 100: NDC 0115-1248-01 Bottles of 1000: NDC 0115-1248-03 20 mg – capsules with white opaque body imprinted with “H32” in black ink and bright orange opaque cap. Bottles of 30: NDC 0115-1249-08 Bottles of 90: NDC 0115-1249-10 Bottles of 100: NDC 0115-1249-01 Bottles of 1000: NDC 0115-1249-03 40 mg – capsules with bright orange opaque body imprinted with “H33” in black ink and dark green opaque cap. Bottles of 30: NDC 0115-1250-08 Bottles of 90: NDC 0115-1250-10 Bottles of 100: NDC 0115-1250-01 Bottles of 1000: NDC 0115-1250-03 80 mg – capsules with white opaque body imprinted with “H34” in black ink and white opaque cap. Bottles of 30: NDC 0115-1251-08 Bottles of 90: NDC 0115-1251-10 Bottles of 100: NDC 0115-1251-01 Bottles of 1000: NDC 0115-1251-03 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. DISPENSE IN A TIGHTLY CLOSED, LIGHT-RESIStanT CONTAINER AS DEFINED IN THE USP, WITH A CHILD-RESIStanT CLOSURE, AS REQUIRED. KEEP OUT OF THE REACH OF CHILDREN.
More pills like CAPSULE H33